This year, about $1.5 billion has landed in state and local government coffers from court settlements made with more than a dozen companies that manufactured, sold, or distributed prescription painkillers and were sued for their role in fueling the opioid crisis.
Medtronic’s chief medical officer of acute care and monitoring departs for new role
Listen to the article 2 min This audio is auto-generated. Please let us know if you have feedback. Dive Brief: Sam Ajizian has left Medtronic
August 30, 2024